Greater Cannabis Company (GCAN) Return on Capital Employed (2018 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Return on Capital Employed of 22.29% in Q1 2026, down 10.91% quarter-over-quarter from 25.02% in Q4 2025, and up 549.0% on a YoY basis from 3.43% in Q1 2025.
Greater Cannabis Company (GCAN) Return on Capital Employed (2018 - 2026) Analysis & Trends
Greater Cannabis Company's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 22.29% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 549.0% year-over-year to 22.29%; the TTM figure through Mar 2026 stood at 22.29% (up 549.0% YoY), while the FY2025 annual figure was 25.66%, up 570.0% from the prior year.
- Return on Capital Employed was 22.29% for Q1 2026 at Greater Cannabis Company, down from 25.02% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 48.98% in Q1 2022 to a low of 15.09% in Q3 2025.
- Historically, Return on Capital Employed has averaged 27.67% across 5 years, with a median of 25.47% in 2024.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed plunged 9665 bps in 2022, then soared 636 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 33.11% in 2022, then decreased by 18 bps to 27.22% in 2023, then slumped by 31 bps to 18.67% in 2024, then soared by 34 bps to 25.02% in 2025, then declined by 11 bps to 22.29% in 2026.
- The last three Return on Capital Employed figures came in at 22.29% (Q1 2026), 25.02% (Q4 2025), and 15.09% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 6.92% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.85% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -1.92% |
| 10 | Greater Cannabis Company | - | - | - | 22.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.29% |
| Dec 31, 2025 | 25.02% |
| Sep 30, 2025 | 15.09% |
| Jun 30, 2025 | 15.99% |
| Mar 31, 2025 | 16.81% |
| Dec 31, 2024 | 18.67% |
| Sep 30, 2024 | 20.66% |
| Jun 30, 2024 | 23.80% |
| Mar 31, 2024 | 25.47% |
| Dec 31, 2023 | 27.22% |
| Sep 30, 2023 | 27.59% |
| Jun 30, 2023 | 27.51% |
| Mar 31, 2023 | 30.11% |
| Dec 31, 2022 | 33.11% |
| Sep 30, 2022 | 46.36% |
| Jun 30, 2022 | 45.67% |
| Mar 31, 2022 | 48.98% |
| Dec 31, 2021 | 83.56% |
| Sep 30, 2021 | 117.28% |
| Jun 30, 2021 | 142.32% |